Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Denosumab for Osteoporosis
Recruiting3 awardsPhase 4
West Orange, New Jersey
This trial is testing Denosumab, a medication that prevents bone loss, in patients with acute spinal cord injury who experience severe bone weakening. The drug works by blocking a protein that causes bones to break down, helping to maintain their strength.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.